Renal function, neurohormonal activation, and survival in patients with chronic heart failure

Circulation

Volumn 102, Issue 2, 2000, Pages 203-210

  Hillege, Hans L ^f   Girbes, Armand R J ^a   De Kam, Pieter J ^f   Boomsma, Frans ^b   De Zeeuw, Dick ^f   Charlesworth, Andrew ^c   Hampton, John R ^d   Van Veldhuisen, Dirk J ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Nottingham Clinical Trial Data Centre   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f NONE

Author keywords

Heart failure; Hormones; Kidney; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROENDOCRINOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034636845     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.2.203     Document Type: Article

References (34)

1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
2. Cowburn PJ, Cleland JG, Coats AJ, et al. Risk stratification in chronic heart failure. Eur Heart J. 1998;19:696-710.
3. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
4. Parameshwar J, Keegan J, Sparrow J, et al. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123:421-426.
5. Packer M. Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition. Eur Heart J. 1990;11(suppl D):44-52.
6. Feenstra J, in't Veld BA, van der Linden PD, et al. Risk factors for mortality in users of ibopamine. Br J Clin Pharmacol. 1998;46:71-77.
7. Madsen BK, Keller N, Christiansen E, et al. Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity. J Card Fail. 1995;1:207-216.
8. Hampton JR, Van Veldhuisen DJ, Kleber FX, et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure: Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet 1997;349:971-977.
9. Van Veldhuisen DJ, Boomsma F, de Kam PJ, et al. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. Eur Heart J. 1998;19:753-760.
10. Ajayi AA. Estimation of creatinine clearance from serum creatinine: utility of the Cockroft and Gault equation in Nigerian patients. Eur J Clin Pharmacol. 1991;40:429-431.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
12. Luke DR, Halstenson CE, Opsahl JA, et al. Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther. 1990;48:503-508.
13. Robert S, Zarowitz BJ, Peterson EL, et al. Predictability of creatinine clearance estimates in critically ill patients. Crit Care Med. 1993;21: 1487-1495.
14. Robertshaw M, Lai KN, Swaminathan R. Prediction of creatinine clearance from plasma creatinine: comparison of five formulae. Br J Clin Pharmacol. 1989;28:275-280.
15. Waller DG, Fleming JS, Ramsey B, et al. The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J. 1991;67:42-46.
16. Damsgaard EM, Froland A, Jorgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300: 297-300.
17. Friedman PJ. Serum creatinine: an independent predictor of survival after stroke. J Intern Med. 1991;229:175-179.
18. Matts JP, Karnegis JN, Campos CT, et al. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction: POSCH group. J Fam Pract. 1993; 36:497-503.
19. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program: the hypertension detection and follow-up program cooperative group. Hypertension. 1989;13:I80-I93.
20. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] trial). Am J Cardiol. 1992;70:479-487.
21. Van den Broek SAJ, Van Veldhuisen DJ, De Graeff PA, et al. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:359-363.
22. Lieverse AG, Van Veldhuisen DJ, Smit AJ, et al. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure. J Cardiovasc Pharmacol. 1995;25:361-367.
23. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure: relationship of cardiac index to kidney function. Drugs. 1990; 39(suppl4):10-21.
24. Leithe ME, Margorien RD, Hermiller JB, et al. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation. 1984;69:57-64.
25. Magri P, Rao MA, Cangianiello S, et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation. 1998;98: 2849-2854.
26. Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299-305.
27. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645-651.
28. Dzau VJ. Renin-angiotensin system and renal circulation in clinical congestive heart failure. Kidney Int Suppl. 1987;20:S203-S209.
29. Elsner D. Changes in neurohumoral systems during the development of congestive heart failure: impact on cardiovascular and renal function. Eur Heart J. 1995;16(suppl N):52-58.
30. Merrill AJ, Morrison JL, Brannon ES. Concentration of renin in renal venous blood in patients with chronic heart failure. Am J Med. 1946;1: 468-472.
31. Zhang PL, Mackenzie HS, Totsune K, et al. Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure. Circ Res. 1995;77:1240-1245.
32. Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934-1942.
33. Cody RJ, Atlas SA. Laragh JH, et al. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986;78: 1362-1374.
34. Tracy RE, MacLean CJ, Reed DM, et al. Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program. Mod Pathol. 1988;1:420-427.